AVR
Price
$6.00
Change
-$0.01 (-0.17%)
Updated
Oct 22 closing price
Capitalization
584.75M
20 days until earnings call
Intraday BUY SELL Signals
NSPR
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Oct 22 closing price
Capitalization
21.31M
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVR vs NSPR

AVR vs NSPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AVR vs. NSPR commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVR is a Hold and NSPR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AVR with price predictions
Oct 22, 2026

AVR's Stochastic Oscillator sits in oversold zone for 22 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +3.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVR advanced for three days, in 91 of 102 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

AVR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for AVR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.326) is normal, around the industry mean (2.874). P/E Ratio (-3.077) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (238.095) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. AVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for NSPR with price predictions
Oct 22, 2026

NSPR's Indicator enters downward trend

The Aroon Indicator for NSPR entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 296 similar instances where the Aroon Indicator formed such a pattern. In 262 of the 296 cases the stock moved lower. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for NSPR crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +3.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSPR advanced for three days, in 154 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

NSPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.676) is normal, around the industry mean (2.874). P/E Ratio (-0.746) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (5.767) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. NSPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
NSPR: Fundamental Ratings
NSPR
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVRNSPR
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
89%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AVR: $6.00 vs. NSPR: $0.46)
Brand notoriety: AVR and NSPR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AVR: 233% vs. NSPR: 441%
Market capitalization -- AVR: $584.75M vs. NSPR: $21.31M
AVR [@Medical/Nursing Services] is valued at $584.75M. NSPR’s [@Medical/Nursing Services] market capitalization is $21.31M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $177.38B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVR’s FA Score shows that 2 FA rating(s) are green while NSPR’s FA Score has 1 green FA rating(s).

  • AVR’s FA Score: 2 green, 3 red.
  • NSPR’s FA Score: 1 green, 4 red.
According to our system of comparison, AVR is a better buy in the long-term than NSPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVR’s TA Score shows that 4 TA indicator(s) are bullish while NSPR’s TA Score has 3 bullish TA indicator(s).

  • AVR’s TA Score: 4 bullish, 2 bearish.
  • NSPR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, AVR is a better buy in the short-term than NSPR.

Price Growth

AVR (@Medical/Nursing Services) experienced а -5.66% price change this week, while NSPR (@Medical/Nursing Services) price change was -5.27% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

Reported Earning Dates

AVR is expected to report earnings on Nov 11, 2026.

NSPR is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
AVR
Daily Signal:
Gain/Loss:
NSPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AVR and

Correlation & Price change

A.I.dvisor tells us that AVR and MYO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVR and MYO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVR
1D Price
Change %
AVR100%
-0.17%
MYO - AVR
30%
Poorly correlated
-3.17%
QSI - AVR
29%
Poorly correlated
-6.50%
CNMD - AVR
27%
Poorly correlated
+4.95%
TXG - AVR
27%
Poorly correlated
-7.73%
DCTH - AVR
26%
Poorly correlated
+0.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REPX51.102.76
+5.71%
Riley Exploration Permian
UNF278.994.99
+1.82%
Unifirst Corp
ELMD26.87-0.45
-1.65%
Electromed
KYNB5.04-0.17
-3.26%
Kyntra Bio Inc
MSTR145.80-7.68
-5.00%
Strategy Inc